misonidazole has been researched along with Neoplasms, Otorhinolaryngologic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benech, J; De Clermont-Gallerande, H; De Mones del Pujol, E; Digue, L; Fernandez, P; Galland-Girodet, S; Hatt, M; Henriques de Figueiredo, B; Lamare, F; Zacharatou, C | 1 |
| Baillet, F; Boisserie, G; Dessard-Diana, B; Housset, M | 1 |
| Baillet, F | 1 |
1 trial(s) available for misonidazole and Neoplasms, Otorhinolaryngologic
| Article | Year |
|---|---|
Positive clinical experience with misonidazole in brachytherapy and external radiotherapy.
Topics: Brachytherapy; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Misonidazole; Otorhinolaryngologic Neoplasms; Radiotherapy Dosage | 1989 |
2 other study(ies) available for misonidazole and Neoplasms, Otorhinolaryngologic
| Article | Year |
|---|---|
Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers.
Topics: Aged; Carcinoma, Squamous Cell; Cell Hypoxia; Humans; Male; Middle Aged; Misonidazole; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tumor Burden | 2015 |
[A new method of curietherapy, more efficient and better tolerated: 2-stage curietherapy with changing of the position of the sources and the radiosensitizer].
Topics: Brachytherapy; Follow-Up Studies; Humans; Iridium; Misonidazole; Otorhinolaryngologic Neoplasms; Radiotherapy Dosage; Radium | 1985 |